Prolonged low-dosage administration of hexamethylmelamine (NC 13875).
D000863:Antacids / Q000627:therapeutic use; D000932:Antiemetics / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001792:Blood Platelets / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D004064:Digestive System / Q000187:drug effects; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007962:Leukocytes / Q000187:drug effects; D008175:Lung Neoplasms / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D012867:Skin / Q000187:drug effects; D013997:Time Factors; D014265:Triethylenemelamine / Q000009:adverse effects
D000863:Antacids; D000932:Antiemetics; D000970:Antineoplastic Agents; D014265:Triethylenemelamine